Skip to main content

Graduate Student Schuck Receives AHA Fellowship

June 16, 2011

Bob Schuck, PharmD, a doctoral student at the UNC Eshelman School of Pharmacy, has received a predoctoral fellowship from the American Heart Association to support his search for new treatments for vascular inflammation and cardiovascular disease. The two-year fellowship will … Read more

Brouwer, Kohn Receive Grants from NC TraCS Institute

February 15, 2011

School faculty members Kim Brouwer, PharmD, PhD, and Harold Kohn, PhD, have received $10,000 grants from the North Carolina Translational and Clinical Sciences Institute. Brouwer, a William R. Kenan Jr. Distinguished Professor and chair of the Division of Pharmacotherapy and … Read more

Brouwer Named Oregon State Alumni Fellow

November 3, 2010

Kim L. R. Brouwer, PharmD, PhD, was named an Alumni Fellow by Oregon State University at a dinner and awards ceremony on October 29 in Corvallis, Oregon. “Dr. Brouwer remains a Beaver at heart, even with the time spent at … Read more

Photos: DPET Fellows Day 2010

June 23, 2010

The Division of Pharmacotherapy and Experimental Therapeutics held its 2010 Fellows Day on Wednesday, June 23. The division’s fellows presented posters of their research, and second-year fellows John An, Angela Yu, Ahsan Naqi Rizwan, Kyle Ellis, Irene La-Beck, Amanda Jones, … Read more

Lee Study: Boosting P450 Enzyme Lowers Blood Pressure

June 8, 2010

Scientists at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill have discovered that increasing levels of a certain enzyme in blood vessels can lower blood pressure, at least in mice, which could bode … Read more

Pollack to Be Dean at Washington State

March 18, 2010

Gary Pollack, PhD, executive associate dean of the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill, will be the new dean of the Washington State University College of Pharmacy starting August 1. “I am … Read more

NIAID Grant Launches Kashuba’s Plan for HIV-Prevention Trials

December 18, 2009

Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world. “I … Read more